Exact Sciences
EXAS
#1382
Rank
NZ$21.15 B
Marketcap
$114.49
Share price
2.34%
Change (1 day)
-9.41%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$5.62 B

According to Exact Sciences's latest financial reports the company's total liabilities are NZ$5.62 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$5.25 B4.88%
2022-12-31NZ$5.01 B4.15%
2021-12-31NZ$4.81 B28.75%
2020-12-31NZ$3.73 B107.16%
2019-12-31NZ$1.80 B43.69%
2018-12-31NZ$1.25 B1041.8%
2017-12-31NZ$0.11 B82.57%
2016-12-31NZ$60.26 M10.83%
2015-12-31NZ$54.37 M78.93%
2014-12-31NZ$30.39 M120.66%
2013-12-31NZ$13.77 M-16.51%
2012-12-31NZ$16.49 M-4.34%
2011-12-31NZ$17.24 M-20.95%
2010-12-31NZ$21.81 M-20.07%
2009-12-31NZ$27.28 M88.97%
2008-12-31NZ$14.44 M34.33%
2007-12-31NZ$10.75 M-15%
2006-12-31NZ$12.64 M-34.63%
2005-12-31NZ$19.34 M-23.84%
2004-12-31NZ$25.4 M-26.45%
2003-12-31NZ$34.54 M54.01%
2002-12-31NZ$22.42 M125.32%
2001-12-31NZ$9.95 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$0.55 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.16 B-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$35.25 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$98.34 B 1,647.92%๐Ÿ‡ซ๐Ÿ‡ท France